Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Lars Thore Burgdorf is active.

Publication


Featured researches published by Lars Thore Burgdorf.


Archive | 2004

Benzimidazole derivatives as raf kinase inhibitors

Hans-Peter Buchstaller; Dirk Finsinger; Matthias Wiesner; Lars Thore Burgdorf; Christiane Amendt; Matthias Grell; Christian Sirrenberg; Frank Zenke


Archive | 2004

Acylhydrazone derivatives and their use in the inhibition, regulation and/or modulation of the signal transduction of kinases

Rolf Gericke; Norbert Beier; Oliver Pöschke; Lars Thore Burgdorf; Helga Drosdat; Florian Lang


Archive | 2008

Pyridine derivatives useful as glucokinase activators

Lars Thore Burgdorf; Norbert Beier; Johannes Gleitz; Christine Charon; Daniel Cravo


Archive | 2005

Pyridinamide derivatives as kinase inhibitors

Lars Thore Burgdorf; Hans-Peter Buchstaller; Frank Stieber; Christiane Amendt; Hartmut Greiner; Matthias Grell; Christ an Sirrenberg; Frank Zenke


Archive | 2009

CARBOXAMIDE-HETEROARYL DERIVATIVES FOR THE TREATMENT OF DIABETES

Lars Thore Burgdorf; Stefan Bender; Christoph Saal; Christine Charon; Norbert Beier


Archive | 2008

N-(PYRAZOLE-3-YL)-BENZAMIDE DERIVATIVES AS GLUCOKINASE ACTIVATORS

Lars Thore Burgdorf; Denis Carniato; Ulrich Emde; Norbert Beier; Johannes Gleitz; Christine Charon


Archive | 2005

Heterocyclic substituted bisarylurea derivatives as kinase inhibitors

Frank Stieber; Alfred Jonczyk; Guenter Hoelzemann; Hans-Peter Buchstaller; Lars Thore Burgdorf; Wilfried Rautenberg; Hartmut Greiner


Archive | 2005

Pyridinamide derivative as kinase inhibitors

Lars Thore Burgdorf; Hans-Peter Buchstaller; Frank Stieber; Christiane Amendt; Hartmut Greiner; Matthias Grell; Christian Sirrenberg; Frank Zenke


Archive | 2007

Indolizine derivatives and their use as antidiabetics

Werner Mederski; Norbert Beier; Lars Thore Burgdorf; Rolf Gericke; Markus Klein; Christos Tsaklakidis


Archive | 2009

5-oxo-2, 3,4,5-tetrahydro-benzo[b]oxepine-4-carboxylic acid amides and 2,3-dihydro-benzo[b]oxepine-4-carboxylic acid amides for treatment and prevention of diabetes typ 1 and 2

Christoph Saal; Lars Thore Burgdorf; Ulrich Emde; Norbert Beier; Johannes Gleitz; Christine Charon

Collaboration


Dive into the Lars Thore Burgdorf's collaboration.

Researchain Logo
Decentralizing Knowledge